FBLN1 inhibits ferroptosis by reducing intracellular free ferrous iron. by Yaping Yuan (2734228)

Subjects:

Knockdown of FBLN1 can promote ferroptosis in LPS-induced ALI. by Yaping Yuan (2734228)

Subjects:

Gene co-expression network analysis of the GSE263867 dataset. by Yaping Yuan (2734228)

Subjects:

LPS induces ferroptosis of lung epithelial cells. by Yaping Yuan (2734228)

Subjects:

Overexpression of <i>FBLN1</i> can inhibit ferroptosis in LPS-induced ALI. by Yaping Yuan (2734228)

Subjects:

FBLN1 regulates ferroptosis by inhibiting TGF-β. by Yaping Yuan (2734228)

Subjects:

Soil bacterial (A) and fungal (B) alpha-diversity indices in mobile and fixed dunes. by Chengchen Pan (287383)

Relative abundances of dominant phyla in soil bacteria (a) and fungi (b) during restoration. by Chengchen Pan (287383)

Regions of significance for the simple block slopes on proportion of risky decisions as a function of past-month nonsuicidal self-injury (NSSI) and task. by Brooke H. Nancekivell (19949839)

The raw data for Fig 8A. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

Establishment of a diabetic rat model. by Lan Zeng (638254)

“…Accordingly, we measured VEGF gene expression and found that it was significantly increased in the retinas of diabetic rats (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3A</a>). …”

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA.... by Emir Matpan (21655811)

“…Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …”

IKK KO in microglia leads to increased accumulation of PK-resistant PrP <i>in vitro</i> but decreased accumulation <i>in vivo.</i> by Arielle J. D. Hay (15456341)

Cycle threshold values at which a specific number of dogs out of 11 dogs was able to detect SARS-CoV-2 in samples from Merida, Yucatán, México. by Víctor M. Vidal-Martínez (18707335)

Subjects:

Table 6 - Gain and loss: Human and environmental wellbeing – drivers of Kilimanjaro’s decreasing biodiversity by Andreas Hemp (730415)

HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters by Arash GhorbanniaDelavar (22563696)

“…<h2>Summary</h2><p dir="ltr">This research introduces <b>HDECO</b> (Hybrid Decreasing Energy and Cost Optimization) — a method designed to reduce both energy consumption and execution cost in cloud datacenters through intelligent virtual machine migration. …”

DALY and HLY in Portugal, 1990–2019. The first graph shows a decreasing trend of DALY and the second graph shows an increasing trend of HLY. by Aida Isabel Tavares (12080156)

Participant retention flowchart. by Carolin Oetzmann (11397968)

“…We identified a 4-class solution: (1) severe with appetite decrease, (2) severe with appetite increase, (3) moderate severity and (4) low severity. …”

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

Cohort characteristics. by Fernanda Talarico (807333)

“…</p><p>Results</p><p>The analysis reveals a significant decrease in all health services utilization from 2016 to 2019, followed by an increase until 2022. …”